APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

SGLT2 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global SGLT2 Inhibitors Industry Growth and Trends Forecast to 2032

29 December 2025102 pages

Choose your research edition.

Industry ResearchSGLT2 Inhibitors Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal SGLT2 Inhibitors Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal SGLT2 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SGLT2 Inhibitors Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal SGLT2 Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global SGLT2 Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for SGLT2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for SGLT2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SGLT2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SGLT2 Inhibitors include Chia Tai-Tianqing Pharmaceutical, Sandoz, Johnson and Johnson, Merck, Kelun Pharmaceutical, Hengrui Medicine, Hansoh Pharmaceutical Group, Boehringer Ingelheim and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global SGLT2 Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The SGLT2 Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global SGLT2 Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to SGLT2 Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global SGLT2 Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

SGLT2 Inhibitors Market by Company

Chia Tai-Tianqing Pharmaceutical

Sandoz

Johnson and Johnson

Merck

Kelun Pharmaceutical

Hengrui Medicine

Hansoh Pharmaceutical Group

Boehringer Ingelheim

Bristol-Myers Squibb

AstraZeneca

Starpharma

Orifarm

SGLT2 Inhibitors Segment by Type

Dapagliflozin

Canagliflozin

Canagliflozin

Other

SGLT2 Inhibitors Segment by Application

Single Drug

Combination Medication

SGLT2 Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SGLT2 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SGLT2 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SGLT2 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of SGLT2 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of SGLT2 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dapagliflozin Table 2. Major Company of Canagliflozin Table 3. Major Company of Canagliflozin Table 4. Major Company of Other Table 5. Global SGLT2 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global SGLT2 Inhibitors Sales by Type (2021-2026) & (Pcs) Table 7. Global SGLT2 Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 8. Global SGLT2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 9. Global SGLT2 Inhibitors Sales Market Share in Value by Type (2021-2026) Table 10. Global SGLT2 Inhibitors Price by Type (2021-2026) & (US$/Pcs) Table 11. Global SGLT2 Inhibitors Sales by Type (2027-2032) & (Pcs) Table 12. Global SGLT2 Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 13. Global SGLT2 Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 14. Global SGLT2 Inhibitors Sales Market Share in Value by Type (2027-2032) Table 15. Global SGLT2 Inhibitors Price by Type (2027-2032) & (US$/Pcs) Table 16. North America SGLT2 Inhibitors Sales by Type (2021-2026) & (Pcs) Table 17. North America SGLT2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Europe SGLT2 Inhibitors Sales by Type (2021-2026) & (Pcs) Table 19. Europe SGLT2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific SGLT2 Inhibitors Sales by Type (2021-2026) & (Pcs) Table 21. Asia-Pacific SGLT2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America SGLT2 Inhibitors Sales by Type (2021-2026) & (Pcs) Table 23. Latin America SGLT2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa SGLT2 Inhibitors Sales by Type (2021-2026) & (Pcs) Table 25. Middle East and Africa SGLT2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 26. SGLT2 Inhibitors Industry Trends Table 27. SGLT2 Inhibitors Industry Drivers Table 28. SGLT2 Inhibitors Industry Opportunities and Challenges Table 29. SGLT2 Inhibitors Industry Restraints Table 30. Global SGLT2 Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global SGLT2 Inhibitors Revenue Market Share by Company (2021-2026) Table 32. Global SGLT2 Inhibitors Sales by Company (2021-2026) & (Pcs) Table 33. Global SGLT2 Inhibitors Sales Share by Company (2021-2026) Table 34. Global SGLT2 Inhibitors Market Price by Company (2021-2026) & (US$/Pcs) Table 35. Global SGLT2 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global SGLT2 Inhibitors Major Company Production Sites and Headquarters Table 37. Global SGLT2 Inhibitors Company, Product Type & Application Table 38. Global SGLT2 Inhibitors Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global SGLT2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global SGLT2 Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global SGLT2 Inhibitors Sales by Region (2021-2026) & (Pcs) Table 43. Global SGLT2 Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 44. Global SGLT2 Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 45. Global SGLT2 Inhibitors Sales Market Share in Value by Region (2021-2026) Table 46. Global SGLT2 Inhibitors Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 47. Global SGLT2 Inhibitors Sales by Region (2027-2032) & (Pcs) Table 48. Global SGLT2 Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 49. Global SGLT2 Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 50. Global SGLT2 Inhibitors Sales Market Share in Value by Region (2027-2032) Table 51. Global SGLT2 Inhibitors Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 52. Global SGLT2 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global SGLT2 Inhibitors Sales by Application (2021-2026) & (Pcs) Table 54. Global SGLT2 Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 55. Global SGLT2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 56. Global SGLT2 Inhibitors Sales Market Share in Value by Application (2021-2026) Table 57. Global SGLT2 Inhibitors Price by Application (2021-2026) & (US$/Pcs) Table 58. Global SGLT2 Inhibitors Sales by Application (2027-2032) & (Pcs) Table 59. Global SGLT2 Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 60. Global SGLT2 Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 61. Global SGLT2 Inhibitors Sales Market Share in Value by Application (2027-2032) Table 62. Global SGLT2 Inhibitors Price by Application (2027-2032) & (US$/Pcs) Table 63. North America SGLT2 Inhibitors Sales by Application (2021-2026) & (Pcs) Table 64. North America SGLT2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Europe SGLT2 Inhibitors Sales by Application (2021-2026) & (Pcs) Table 66. Europe SGLT2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific SGLT2 Inhibitors Sales by Application (2021-2026) & (Pcs) Table 68. Asia-Pacific SGLT2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America SGLT2 Inhibitors Sales by Application (2021-2026) & (Pcs) Table 70. Latin America SGLT2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa SGLT2 Inhibitors Sales by Application (2021-2026) & (Pcs) Table 72. Middle East and Africa SGLT2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 73. Chia Tai-Tianqing Pharmaceutical Company Information Table 74. Chia Tai-Tianqing Pharmaceutical Business Overview Table 75. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 76. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Portfolio Table 77. Chia Tai-Tianqing Pharmaceutical Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 81. Sandoz SGLT2 Inhibitors Product Portfolio Table 82. Sandoz Recent Development Table 83. Johnson and Johnson Company Information Table 84. Johnson and Johnson Business Overview Table 85. Johnson and Johnson SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 86. Johnson and Johnson SGLT2 Inhibitors Product Portfolio Table 87. Johnson and Johnson Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 91. Merck SGLT2 Inhibitors Product Portfolio Table 92. Merck Recent Development Table 93. Kelun Pharmaceutical Company Information Table 94. Kelun Pharmaceutical Business Overview Table 95. Kelun Pharmaceutical SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 96. Kelun Pharmaceutical SGLT2 Inhibitors Product Portfolio Table 97. Kelun Pharmaceutical Recent Development Table 98. Hengrui Medicine Company Information Table 99. Hengrui Medicine Business Overview Table 100. Hengrui Medicine SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 101. Hengrui Medicine SGLT2 Inhibitors Product Portfolio Table 102. Hengrui Medicine Recent Development Table 103. Hansoh Pharmaceutical Group Company Information Table 104. Hansoh Pharmaceutical Group Business Overview Table 105. Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 106. Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Portfolio Table 107. Hansoh Pharmaceutical Group Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim SGLT2 Inhibitors Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Bristol-Myers Squibb Company Information Table 114. Bristol-Myers Squibb Business Overview Table 115. Bristol-Myers Squibb SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 116. Bristol-Myers Squibb SGLT2 Inhibitors Product Portfolio Table 117. Bristol-Myers Squibb Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 121. AstraZeneca SGLT2 Inhibitors Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Starpharma Company Information Table 124. Starpharma Business Overview Table 125. Starpharma SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 126. Starpharma SGLT2 Inhibitors Product Portfolio Table 127. Starpharma Recent Development Table 128. Orifarm Company Information Table 129. Orifarm Business Overview Table 130. Orifarm SGLT2 Inhibitors Sales (Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 131. Orifarm SGLT2 Inhibitors Product Portfolio Table 132. Orifarm Recent Development Table 133. North America SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (Pcs): 2021 VS 2025 VS 2032 Table 134. North America SGLT2 Inhibitors Sales by Country (2021-2026) & (Pcs) Table 135. North America SGLT2 Inhibitors Sales Market Share by Country (2021-2026) Table 136. North America SGLT2 Inhibitors Sales Forecast by Country (2027-2032) & (Pcs) Table 137. North America SGLT2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 138. North America SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America SGLT2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 140. North America SGLT2 Inhibitors Market Share by Country (2021-2026) Table 141. North America SGLT2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America SGLT2 Inhibitors Market Share Forecast by Country (2027-2032) Table 143. Europe SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (Pcs): 2021 VS 2025 VS 2032 Table 144. Europe SGLT2 Inhibitors Sales by Country (2021-2026) & (Pcs) Table 145. Europe SGLT2 Inhibitors Sales Market Share by Country (2021-2026) Table 146. Europe SGLT2 Inhibitors Sales Forecast by Country (2027-2032) & (Pcs) Table 147. Europe SGLT2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 148. Europe SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe SGLT2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe SGLT2 Inhibitors Market Share by Country (2021-2026) Table 151. Europe SGLT2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe SGLT2 Inhibitors Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (Pcs): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific SGLT2 Inhibitors Sales by Country (2021-2026) & (Pcs) Table 155. Asia-Pacific SGLT2 Inhibitors Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific SGLT2 Inhibitors Sales Forecast by Country (2027-2032) & (Pcs) Table 157. Asia-Pacific SGLT2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific SGLT2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific SGLT2 Inhibitors Market Share by Country (2021-2026) Table 161. Asia-Pacific SGLT2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific SGLT2 Inhibitors Market Share Forecast by Country (2027-2032) Table 163. Latin America SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (Pcs): 2021 VS 2025 VS 2032 Table 164. Latin America SGLT2 Inhibitors Sales by Country (2021-2026) & (Pcs) Table 165. Latin America SGLT2 Inhibitors Sales Market Share by Country (2021-2026) Table 166. Latin America SGLT2 Inhibitors Sales Forecast by Country (2027-2032) & (Pcs) Table 167. Latin America SGLT2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America SGLT2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America SGLT2 Inhibitors Market Share by Country (2021-2026) Table 171. Latin America SGLT2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America SGLT2 Inhibitors Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (Pcs): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa SGLT2 Inhibitors Sales by Country (2021-2026) & (Pcs) Table 175. Middle East and Africa SGLT2 Inhibitors Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa SGLT2 Inhibitors Sales Forecast by Country (2027-2032) & (Pcs) Table 177. Middle East and Africa SGLT2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa SGLT2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa SGLT2 Inhibitors Market Share by Country (2021-2026) Table 181. Middle East and Africa SGLT2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa SGLT2 Inhibitors Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. SGLT2 Inhibitors Distributors List Table 186. SGLT2 Inhibitors Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. SGLT2 Inhibitors Image Figure 2. Global SGLT2 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SGLT2 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global SGLT2 Inhibitors Sales (2021-2032) & (Pcs) Figure 5. Dapagliflozin Image Figure 6. Global Dapagliflozin Sales YoY Growth (2021-2032) & (Pcs) Figure 7. Canagliflozin Image Figure 8. Global Canagliflozin Sales YoY Growth (2021-2032) & (Pcs) Figure 9. Canagliflozin Image Figure 10. Global Canagliflozin Sales YoY Growth (2021-2032) & (Pcs) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (Pcs) Figure 13. Global SGLT2 Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global SGLT2 Inhibitors Market Share by Type 2025 VS 2032 Figure 15. North America SGLT2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. North America SGLT2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Europe SGLT2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Europe SGLT2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific SGLT2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific SGLT2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Latin America SGLT2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 22. Latin America SGLT2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa SGLT2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa SGLT2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 SGLT2 Inhibitors Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Single Drug Image Figure 28. Global Single Drug Sales YoY Growth (2021-2032) & (Pcs) Figure 29. Combination Medication Image Figure 30. Global Combination Medication Sales YoY Growth (2021-2032) & (Pcs) Figure 31. Global SGLT2 Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global SGLT2 Inhibitors Market Share by Application 2025 VS 2032 Figure 33. North America SGLT2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 34. North America SGLT2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 35. Europe SGLT2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. Europe SGLT2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific SGLT2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific SGLT2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Latin America SGLT2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Latin America SGLT2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa SGLT2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa SGLT2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. North America SGLT2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Figure 44. North America SGLT2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America SGLT2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America SGLT2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe SGLT2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Figure 48. Europe SGLT2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe SGLT2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe SGLT2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific SGLT2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Figure 52. Asia-Pacific SGLT2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific SGLT2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific SGLT2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America SGLT2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Figure 56. Latin America SGLT2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America SGLT2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America SGLT2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa SGLT2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Figure 60. Middle East and Africa SGLT2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa SGLT2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa SGLT2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. SGLT2 Inhibitors Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. SGLT2 Inhibitors Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Dapagliflozin
  • Canagliflozin
  • Canagliflozin
  • Other
Applications
  • Single Drug
  • Combination Medication
Companies covered
  • Chia Tai-Tianqing Pharmaceutical
  • Sandoz
  • Johnson and Johnson
  • Merck
  • Kelun Pharmaceutical
  • Hengrui Medicine
  • Hansoh Pharmaceutical Group
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • AstraZeneca
  • Starpharma
  • Orifarm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global SGLT2 Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global SGLT2 Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 SGLT2 Inhibitors Market by Type
  6. 1.3.1 Dapagliflozin
  7. 1.3.2 Canagliflozin
  8. 1.3.3 Canagliflozin
  9. 1.3.4 Other
  10. 1.4 Global SGLT2 Inhibitors Market Size by Type
  11. 1.4.1 Global SGLT2 Inhibitors Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global SGLT2 Inhibitors Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global SGLT2 Inhibitors Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America SGLT2 Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe SGLT2 Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific SGLT2 Inhibitors Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America SGLT2 Inhibitors Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa SGLT2 Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 SGLT2 Inhibitors Industry Trends
  2. 2.2 SGLT2 Inhibitors Industry Drivers
  3. 2.3 SGLT2 Inhibitors Industry Opportunities and Challenges
  4. 2.4 SGLT2 Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by SGLT2 Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by SGLT2 Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by SGLT2 Inhibitors Price (2021-2026)
  4. 3.4 Global SGLT2 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global SGLT2 Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global SGLT2 Inhibitors Company, Product Type & Application
  7. 3.7 Global SGLT2 Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global SGLT2 Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 SGLT2 Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 SGLT2 Inhibitors Tier 1, Tier 2, and Tier 3
4 SGLT2 Inhibitors Regional Status and Outlook
  1. 4.1 Global SGLT2 Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global SGLT2 Inhibitors Historic Market Size by Region
  3. 4.2.1 Global SGLT2 Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global SGLT2 Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global SGLT2 Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global SGLT2 Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global SGLT2 Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global SGLT2 Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global SGLT2 Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 SGLT2 Inhibitors by Application
  1. 5.1 SGLT2 Inhibitors Market by Application
  2. 5.1.1 Single Drug
  3. 5.1.2 Combination Medication
  4. 5.2 Global SGLT2 Inhibitors Market Size by Application
  5. 5.2.1 Global SGLT2 Inhibitors Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global SGLT2 Inhibitors Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global SGLT2 Inhibitors Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America SGLT2 Inhibitors Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe SGLT2 Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific SGLT2 Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America SGLT2 Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa SGLT2 Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai-Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai-Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai-Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Portfolio
  6. 6.1.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz SGLT2 Inhibitors Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Johnson and Johnson
  14. 6.3.1 Johnson and Johnson Company Information
  15. 6.3.2 Johnson and Johnson Business Overview
  16. 6.3.3 Johnson and Johnson SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson and Johnson SGLT2 Inhibitors Product Portfolio
  18. 6.3.5 Johnson and Johnson Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck SGLT2 Inhibitors Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Kelun Pharmaceutical
  26. 6.5.1 Kelun Pharmaceutical Company Information
  27. 6.5.2 Kelun Pharmaceutical Business Overview
  28. 6.5.3 Kelun Pharmaceutical SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kelun Pharmaceutical SGLT2 Inhibitors Product Portfolio
  30. 6.5.5 Kelun Pharmaceutical Recent Developments
  31. 6.6 Hengrui Medicine
  32. 6.6.1 Hengrui Medicine Company Information
  33. 6.6.2 Hengrui Medicine Business Overview
  34. 6.6.3 Hengrui Medicine SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hengrui Medicine SGLT2 Inhibitors Product Portfolio
  36. 6.6.5 Hengrui Medicine Recent Developments
  37. 6.7 Hansoh Pharmaceutical Group
  38. 6.7.1 Hansoh Pharmaceutical Group Company Information
  39. 6.7.2 Hansoh Pharmaceutical Group Business Overview
  40. 6.7.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Portfolio
  42. 6.7.5 Hansoh Pharmaceutical Group Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Boehringer Ingelheim SGLT2 Inhibitors Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
  49. 6.9 Bristol-Myers Squibb
  50. 6.9.1 Bristol-Myers Squibb Company Information
  51. 6.9.2 Bristol-Myers Squibb Business Overview
  52. 6.9.3 Bristol-Myers Squibb SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bristol-Myers Squibb SGLT2 Inhibitors Product Portfolio
  54. 6.9.5 Bristol-Myers Squibb Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca SGLT2 Inhibitors Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 Starpharma
  62. 6.11.1 Starpharma Company Information
  63. 6.11.2 Starpharma Business Overview
  64. 6.11.3 Starpharma SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Starpharma SGLT2 Inhibitors Product Portfolio
  66. 6.11.5 Starpharma Recent Developments
  67. 6.12 Orifarm
  68. 6.12.1 Orifarm Company Information
  69. 6.12.2 Orifarm Business Overview
  70. 6.12.3 Orifarm SGLT2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Orifarm SGLT2 Inhibitors Product Portfolio
  72. 6.12.5 Orifarm Recent Developments
7 North America by Country
  1. 7.1 North America SGLT2 Inhibitors Sales by Country
  2. 7.1.1 North America SGLT2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America SGLT2 Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America SGLT2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America SGLT2 Inhibitors Market Size by Country
  6. 7.2.1 North America SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America SGLT2 Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America SGLT2 Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe SGLT2 Inhibitors Sales by Country
  2. 8.1.1 Europe SGLT2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe SGLT2 Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe SGLT2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe SGLT2 Inhibitors Market Size by Country
  6. 8.2.1 Europe SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe SGLT2 Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe SGLT2 Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific SGLT2 Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific SGLT2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific SGLT2 Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific SGLT2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific SGLT2 Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific SGLT2 Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific SGLT2 Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America SGLT2 Inhibitors Sales by Country
  2. 10.1.1 South America SGLT2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America SGLT2 Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America SGLT2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America SGLT2 Inhibitors Market Size by Country
  6. 10.2.1 South America SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America SGLT2 Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America SGLT2 Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa SGLT2 Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa SGLT2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa SGLT2 Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa SGLT2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa SGLT2 Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa SGLT2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa SGLT2 Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa SGLT2 Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 SGLT2 Inhibitors Value Chain Analysis
  2. 12.1.1 SGLT2 Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 SGLT2 Inhibitors Production Mode & Process
  7. 12.2 SGLT2 Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 SGLT2 Inhibitors Distributors
  10. 12.2.3 SGLT2 Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst